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ABSTRACT
MicroRNAs (miRNAs) are prevalent regulatory RNAs
that mediate gene silencing and play key roles
in diverse cellular processes. While synthetic RNA-
based regulatory systems that integrate regulatory
and sensing functions have been demonstrated, the
lack of detail on miRNA structure–function relation-
ships has limited the development of integrated
control systems based on miRNA silencing. Using
an elucidated relationship between Drosha process-
ing and the single-stranded nature of the miRNA
basal segments, we developed a strategy for design-
ing ligand-responsive miRNAs. We demonstrate that
ligand binding to an aptamer integrated into the
miRNA basal segments inhibits Drosha processing,
resulting in titratable control over gene silencing.
The generality of this control strategy was shown
for three aptamer–small molecule ligand pairs. The
platform can be extended to the design of synthetic
miRNAs clusters, cis-acting miRNAs and self-
targeting miRNAs that act both in cis and trans,
enabling fine-tuning of the regulatory strength and
dynamics. The ability of our ligand-responsive
miRNA platform to respond to user-defined inputs,
undergo regulatory performance tuning and display
scalable combinatorial control schemes will help
advance applications in biological research and
applied medicine.
INTRODUCTION
MicroRNAs (miRNAs) comprise a conserved class of
small non-coding RNAs that direct targeted gene silencing
through the RNA interference (RNAi) pathway in humans
and other eukaryotes. Most miRNAs are encoded within
long transcripts transcribed from Pol II promoters (1,2).
The primary (pri-)miRNA is initially processed to an
65-nt precursor (pre-)miRNA by the Microprocessor
(3–5) composed of the cleaving enzyme Drosha and the
RNA-binding protein DGCR8. Following pri-miRNA
cleavage and export from the nucleus, the pre-miRNA
is processed by Dicer to a 22- to 25-nt miRNA duplex.
One of the duplex strands termed the mature miRNA
is incorporated into the RNA-induced silencing complex
(RISC), which subsequently cleaves or translationally
represses the target transcript depending on the degree
of complementarity between the guide sequence of
the miRNA and the target. miRNA-mediated gene regula-
tion has been implicated in diverse biological processes
ranging from development to angiogenesis and may be
involved in the regulation of a majority of the human
genome (6).
Engineered genetic systems that display ligand control
of miRNA-mediated gene silencing will provide a
powerful and versatile means to control transgene and
endogenous gene expression. Recently, researchers have
designed synthetic RNA-based regulatory systems
that integrate sensing and gene-regulatory functions,
where the former are encoded in RNA aptamer sequences
that recognize small molecule ligands (7,8). Such integrated
ligand-responsive RNA-based control systems offer
several advantages over more traditional protein-based
regulatory systems in avoiding potential immunogenicity
of heterologous protein components and providing a
more tunable, compact control system. In addition, as
aptamers can be selected against a wide range of biomol-
ecules (9), such integrated RNA systems provide platforms
for gene expression control in response to potentially
any ligand.
*To whom correspondence should be addressed. Tel: +1 650 721 6371; Fax: +1 650 721 6602; Email: csmolke@stanford.edu
Published online 11 December 2010 Nucleic Acids Research, 2011, Vol. 39, No. 7 2981–2994
doi:10.1093/nar/gkq954
 The Author(s) 2010. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.5), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Recently, RNA-based control systems have been
developed that mediate gene silencing through the
RNAi pathway in response to small molecule ligands.
One system utilized an allosteric ribozyme to indirectly
control miRNA silencing activity (10). Integrated systems
that directly couple aptamers to intermediate substrates in
the RNAi processing pathway, small hairpin RNAs
(shRNAs), have also been demonstrated (11–13). These
integrated designs linked small-molecule RNA aptamers
to the loop region of shRNA elements to modulate
the extent of Dicer processing and subsequent gene
silencing through ligand-binding events based on known
structural requirements for efficient Dicer processing
(11,12). However, the adopted mode of ligand control
inherently reduced silencing (12) and ligand regulation
through Dicer processing restricts molecular sensing to
cytoplasmic ligands. In addition, the in vivo toxicity of
shRNAs (14–16) establish significant hurdles toward
broader implementation of shRNA-based control
systems. Finally, the expression architectures of all of
these systems require additional promoter-RNA constructs
to expand the number of ligand-responsive regulatory
RNAs, which represents a challenge for therapeutic
applications. Many of these practical application
issues may be circumvented through the implementation of
integrated ligand-responsive miRNAs (17). Unfortunately,
the current shRNA-based control systems cannot be
readily converted into functional miRNA-based control
systems as modification of the terminal loop has
been shown to limit Drosha processing in vitro and
in vivo (18).
Here, we demonstrate the design of integrated
ligand-responsive miRNAs that do not require modifica-
tion of the miRNA terminal loop. We also demonstrate
the implementation of the miRNA system in regulatory
circuits that tune the resulting regulatory response. We
utilized a synthetic approach to elucidate more precise
structural requirements for miRNA processing, specific-
ally that the bulge size in the miRNA basal segments
dictates the extent of Drosha processing and in vivo
silencing. By integrating an aptamer into the miRNA
basal segments, we demonstrate that aptamer–ligand-
binding interactions can be used to sufficiently increase
the local structure in the miRNA basal segment region,
such that Drosha processing and subsequent gene
silencing are inhibited with increasing ligand concen-
tration. The sequence flexibility of the basal segments
enables the introduction of different aptamer sequences
in this region, resulting in a modular design framework
that allows modification of the detected ligand or target
gene. We further engineered circuits comprising clusters
of ligand-responsive miRNAs and self-targeting ligand-
responsive miRNAs. The circuits offer tunable and
stringent control over gene expression and, in the case of
miRNA clusters and cis-acting miRNAs, are similar to
circuits found in nature. Our integrated ligand-responsive
miRNA framework offers considerable versatility for
genetic control and will provide a broadly useful tool
supporting basic research and new applications in
biotechnology and medicine.
MATERIALS AND METHODS
Plasmid construction
The coding region of DsRed-Express was initially cloned
with the consensus Kozak sequence (CGCCACC) into the
NheI/XhoI restriction sites of pcDNA3.1(+) to create
pCS350 (Supplementary Figure S1). pcDNA3.1(+)
contains the constitutive CMV promoter upstream of a
multi-cloning site. Ligand-responsive and control
miRNAs reported in Supplementary Table S1 were
cloned into XbaI/ApaI downstream of the DsRed-
Express coding region. To construct synthetic miRNA
clusters, additional miRNAs were amplified from the
miRNA-containing plasmid, digested with AvrII/XhoI
and iteratively inserted into XhoI/XbaI within the same
plasmid. For the 2-nt spacer, the second miRNA (th3) was
separately amplified without a DNA template and
inserted. For all other spacer lengths, the original
miRNA was amplified with a common forward primer
and a reverse primer that hybridizes different distances
downstream of the miRNA: Sp.fwd, 50-GTTCCTGTAG
ACGGCTCTC-30; Sp1.rev, 50-AATACCTAGGCTGAT
CAGCGGGTTT-30; Sp2.rev, 50-AATACCTAGGAGGG
GCAAACAACAG-30; Sp3.rev, 50-AATACCTAGGAAA
GGACAGTGGGAGTG-30. To make stable cell lines har-
boring the ligand-responsive miRNA constructs, the
coding region of DsRed-Express was replaced with
EGFP and the entire genetic construct was excised with
NheI/NsiI and cloned into the same sites in pcDNA5/
FRT (Invitrogen). Prior to insertion, the NsiI site was
introduced into this plasmid at position 1524 using
site-directed mutagenesis.
For the inducible promoter studies, the tetO-CMV
promoter was PCR amplified from pTRE-Tight
(Clontech) and inserted into BglII/NheI of pCS350,
thereby replacing the original CMV promoter. The
control miRNA (wt) was inserted into XbaI/ApaI
downstream of the DsRed-Express coding region to
create ptetO-wt. All restriction enzymes and T4 DNA
ligase were purchased from New England Biolabs. All
constructs were sequence-verified (Laragen and Elim
Biopharmaceuticals).
RNA preparation
Internally radiolabeled RNAs were transcribed in vitro
from an annealed template containing the T7 promoter
(50-TTCTAATACGACTCACTATAGGG-30, where G is
the first transcribed nucleotide) using the Ampliscribe T7
transcription kit (Epicentre) according to the manufactur-
er’s instructions with [a-32P]-GTP. Following transcrip-
tion and DNase I treatment, the transcription product
was purified through a NucAway clean-up column
(Ambion) according to the manufacturer’s instructions
and gel-purified by PAGE.
Drosha cleavage assays
In vitro assays were conducted as described previously (19).
Briefly, the Drosha complex was immunopurified from
293T cells transiently transfected with pCK-Drosha-
FLAG and pCK-DGCR8-FLAG (9:1 mass ratio).
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Two days post-transfection, cells were lysed using M-PER
(Pierce) according to the manufacturer’s instructions and
the resulting supernatant was incubated with anti-FLAG
M2 affinity beads (Sigma Aldrich) for at least 1 h at 4C
with rotation. The beads were then washed with lysis
buffer (20mM Tris–HCl pH 8.0, 100mM KCl, 0.2mM
EDTA) five times and evenly divided for the in vitro
assays (two in vitro reactions from a 10-cm transfection
dish). Radiolabeled RNAs (105 cpm, 3 ml) were
combined with 0.75ml RNasin (Promega), 3 ml reaction
buffer (64mM MgCl2), 8.25ml water and 15 ml
immunopurified Drosha complex. After an incubation of
90min at 37C, the reaction was terminated with the
addition of 0.5 M sodium acetate and 0.02% sodium
dodecyl sulfate (SDS), phenol:chloroform extracted and
ethanol precipitated. Samples were then resuspended in
15 ml RNA loading buffer (95% formamide, 0.02% SDS,
0.025% bromophenol blue, 0.025% xylene cyanol FF)
and resolved on a 12.5% denaturing polyacrylamide gel.
The RNA decades ladder (Ambion) was used as a size
marker.
Cell culture and transfection
HEK 293 cells stably expressing d2EGFP and Flp-In-293
cells were maintained in DMEM supplemented with 10%
FBS at 37C in a 5% CO2-humidified incubator. Transient
transfections were conducted with FuGENE 6 (Roche)
according to the manufacturer’s instructions 1 day after
seeding. Immediately prior to transfection, the media
was supplemented with the appropriate ligand at the
specified concentration. Ligand concentrations were
selected to maximize the regulatory response without
severely compromising cell viability over the course of
the transient assays. For characterization of ligand-
regulated miRNA systems, single-plasmid transfections
were performed using 250 ng of DNA plasmid in each
500-ml transfection sample. For inducible promoter
studies, three-plasmid transfections were performed on
293 cells stably expressing d2EGFP using 10 ng of
pCS350, 72ng of ptetO-wt and 168 ng of pTet-Off
(Clontech) encoding the tetracycline transactivator
(tTA). The amounts of ptetO-wt and pTet-OFF were
selected to maximize expression from the ptetO
promoter while maintaining a total mass of transfected
plasmid of 250 ng (Supplementary Figure S2). The media
was replaced 2 days post-transfection.
Cells were trypsinized and subjected to flow cytometry
analysis on a Cell Lab Quanta SC MPL (Beckman
Coulter) 3 days post-transfection, and the resulting data
were analyzed using the FlowJo software (Tree Star). Cells
were initially gated for viability by electronic volume and
side scatter. GFP and DsRed fluorescence of viable cells
were measured through 525- and 670-nm band-pass filters,
respectively, after excitation with a 488-nm laser.
Detectable DsRed levels served as a transfection control
to gate between transfected and untransfected cells, where
DsRed was detectable even for the constructs containing
four miRNAs (Supplementary Figure S3). GFP levels
were calculated as the median fluorescence of the trans-
fected population divided by that of the untransfected
population (12). This normalization approach corrected
for the bias from pleiotropic effects associated with each
small molecule. All ratios were normalized to the GFP
value for the construct lacking a miRNA under the
same conditions. Reported DsRed measurements equal
the mean fluorescence value of the transfected population
divided by the mean fluorescence value for the construct
lacking a miRNA. Here, the mean value was selected
because of the high variability associated with transient
plasmid-based expression of fluorescent proteins.
Reported data are averages of two or more replicates of
independently transfected wells in the same cell-culture
plate. Results from the cell-culture assays were similar
across repeated independent experiments (Supplementary
Figure S4).
Stable transfection of 293-Flp-In cell lines was per-
formed using the Flp-In recombinase system (Invitrogen)
according to the manufacturer’s instructions to generate
isogenic stable cell lines. Integrants were selected using
200 mg/ml hygromycin B (Invitrogen), whereas stable cell
lines were maintained in 50 mg/ml hygromycin B. The pro-
cedure described above for the fluorescence expression
analysis of transiently transfected cell populations was
used to analyze the stable cell lines with notable excep-
tions. Normalization of flow cytometry data to
untransfected cells was not performed as all cells express
the integrated construct, and all data were normalized to
cells lacking a miRNA and grown in the absence of theo-
phylline. Normalization to cells grown under the same
conditions was not performed since theophylline differen-
tially affected the two negative controls: no miRNA and a
self-targeting miRNA lacking the theophylline aptamer.
The different effects on GFP levels in the no miRNA
and wt samples from theophylline addition may be
attributed to differences in perturbations induced by theo-
phylline stress on unregulated genes and genes regulated
by a self-targeting miRNA.
Other methods
See Supplementary Data for remaining methods,
including qRT–PCR and the design of mature miRNA
sequences.
RESULTS
Extent of structure in the basal segments dictates Drosha
processing and gene silencing
miRNAs can be partitioned into four domains: the
miRNA loop, the upper stem, the lower stem and the
basal segments (Figure 1A). Each domain exhibits
unique structural requirements for efficient Drosha
processing and RISC activation (20–23). The miRNA
loop is unstructured, the upper stem encodes the mature
miRNA and exhibits extensive base pairing interactions,
the lower stem serves as a ruler to designate the Drosha
cleavage site and exhibits fewer base pairing interactions
than the upper stem, and the basal segments are generally
single-stranded.
In vitro studies probing the structural contribution of
the basal segments to efficient Drosha processing have
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shown that mutating the sequence of this domain to form
extensive base pairing interactions abolishes Drosha pro-
cessing (21,23). These results suggest a mechanism for
regulating Drosha processing by regulating the structure
of the basal segments. To utilize this potential mechanism
as a design strategy, we needed to develop a more
thorough understanding of how structure—and, in par-
ticular, the extents of structure—in the basal segments
affect Drosha processing and RNAi-mediated gene
silencing in vivo. Therefore, we examined the relationship
between bulge size in the miRNA basal segments, in vitro
Drosha processing and in vivo gene silencing.
We performed in vitro Drosha cleavage assays that
mimic the first step in miRNA biogenesis to examine the
relationship between bulge size and Drosha processing.
RNAs with varying bulge sizes in the basal segments
(Figure 1B) were transcribed in vitro, incubated with
immunopurified Drosha and resolved by PAGE
(Figure 1C). In vitro Drosha cleavage assays using
similar miRNAs were previously shown to produce a
pre-miRNA of 61 nt (3). We found that decreasing the
size of the loop from 18 to 8 nt greatly reduced the
appearance of the 61-nt pre-miRNA (Figure 1C, black
boxes). Furthermore, decreasing the size of the loop
resulted in a corresponding increase in abortive processing
(Figure 1C, white boxes). Previous in vitro Drosha
cleavage assays also yielded abortive processing, which
was attributed to DGCR8 recognition of the terminal
loop instead of the miRNA basal segments (23). The
in vitro assay results suggest that Drosha cleavage is sen-
sitive to intermediate extents of structure in the basal
segments.
To examine the relationship between bulge size in the
basal segments and gene silencing, we developed a
A C
B
D
E
Figure 1. Extent of structure in the basal segments dictates miRNA processing and target gene silencing. (A) General domains of a pri-miRNA.
(B) Sequence and secondary structure of minimal pri-miRNAs with different bulge sizes in the basal segments. Mature miRNA sequence targeting
GFP is shown in green. The bulge sequences are demarcated by yellow boxes. Black arrows indicate the predicted Drosha cleavage site for productive
processing 11-bp downstream of the basal segments (23). White arrows indicate the predicted Drosha cleavage site for abortive processing 11-bp
upstream of the terminal loop (23). (C) PAGE analysis of the minimal pri-miRNAs subjected to the Drosha cleavage assay. Black and white boxes
mark the general locations of productive and abortive cleavage products, respectively. The three bands representing full-length m1 presumably arose
from spontaneous cleavage of the unstructured bulge during or after gel extraction. (D) Schematic of the miRNA regulatory system in the cell-culture
assay. GFP-targeting miRNAs were placed within the 30 UTR of the transcript encoding DsRed-Express. 293 GFP cells transiently transfected with
each construct were subjected to flow cytometry analysis. (E) Relative GFP levels obtained from the cell-culture assay for constructs harboring
miRNAs with varying bulge sizes. See ‘Materials and Methods’ section for a description of data normalization. Error bars reflect the range of values
from two independent transfections conducted in the same cell-culture plate. See Supplementary Figure S4A for results from an independent
transfection experiment for (E).
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general cell-culture assay for miRNA activity
(Figure 1D). A miRNA designed to target a transcript
encoding the green fluorescent protein (GFP) was
inserted into the 30 UTR of a gene encoding the fluores-
cent protein DsRed-Express. Plasmid DNA encoding the
DsRed-Express construct was transfected into HEK 293
cells stably expressing GFP. The level of
miRNA-mediated gene silencing was determined by
flow cytometry analysis. Using the cell-culture assay,
miRNAs with the same bulges as in the in vitro experi-
ments were tested for silencing efficiency. Flow cytometry
results supported the data from the in vitro Drosha
cleavage assays, as smaller bulge sizes showed reduced
GFP silencing (Figure 1E). Negligible silencing of GFP
was observed for the 11- and 8-nt bulges. These results
suggest that proper Drosha processing and gene silencing
correlate with the size of the bulge in the miRNA basal
segments and >11 nt are required in the bulge to induce
gene silencing.
Aptamer integration renders miRNA processing sensitive
to a small-molecule ligand
Aptamers often undergo transitions from relatively un-
structured to structured conformations upon ligand
binding, a phenomenon termed adaptive recognition
(24). We developed a design strategy based on this
phenomenon and the elucidated dependence of Drosha
processing on the structure of the basal segments to intro-
duce ligand control of miRNA-mediated gene silencing
(Figure 2A). Through integration of an aptamer into the
basal segments of a miRNA, we hypothesized that the
aptamer–ligand-binding interactions would be able to suf-
ficiently decrease the unstructured nature of that region,
thereby inhibiting proper processing and subsequent gene
silencing (Figure 2B).
We first examined the ability of an aptamer to mediate
ligand control of Drosha processing. The theophylline
aptamer (25) was inserted into the basal segments
domain directly adjacent to the lower stem of a GFP-
targeting miRNA (Figure 2C). The resulting miRNA
(th1) was transcribed in vitro and subjected to the
Drosha cleavage assay in the presence or absence of
theophylline. The primary products of Drosha processing
for th1 and a control miRNA (m1) were both 61 nt, the
expected size for the pre-miRNA (3,23) (Figure 2D). In
addition, the presence of theophylline inhibited proper
processing of the aptamer-containing miRNA, resulting
in an alternative cleavage pattern similar to that
observed from miRNAs with smaller bulges (Figure 1C).
The control miRNA exhibited negligible theophylline
dependence, suggesting that ligand binding to an
aptamer located within the basal segments can control
Drosha processing.
We next examined whether theophylline regulation of
Drosha processing resulted in ligand-mediated control of
gene silencing by testing the silencing efficiency of the th1
miRNA using the cell-culture assay. Extensive base
pairing below the bulge encoded in the aptamer
sequence was incorporated to ensure proper aptamer
folding. We also included a GFP-targeting miRNA with
basal segments similar to the natural miRNA miR-30a as
a control (wt, Supplementary Figure S5). Transient trans-
fections were conducted in the presence of varying
concentrations of theophylline. Results show that both
miRNA constructs silenced GFP with comparable
strength (17 and 25% basal levels for wt and th1, respect-
ively) in the absence of theophylline (Figure 2E). Adding
theophylline to cells transfected with the miRNA con-
struct containing the theophylline aptamer resulted in a
2.4-fold increase in GFP levels. The theophylline-
dependent effect was observed at a minimal concentration
of 0.1mM theophylline, as observed in other RNA-based
regulatory systems using this aptamer (11,12,26). In
contrast, silencing by the miRNA construct lacking the
aptamer was insensitive to theophylline. Silencing by
both miRNAs was insensitive to the presence of caffeine
(Figure 2F), a molecule that differs from theophylline by a
single methyl group and binds the theophylline aptamer
with a 10 000-fold lower affinity (25). A caffeine concen-
tration of 1mM was used to avoid the pronounced
toxicity observed at higher concentrations (11). The
results demonstrate that the observed effect of theophyl-
line on miRNA-mediated gene silencing is specific to the
incorporation of the theophylline aptamer into the basal
segments of the miRNA.
We also compared the quantitative response properties
of our ligand-responsive miRNA system to the tet indu-
cible promoter system, which is often used in conditional
gene silencing (27). To most closely match our
experimental setup, we inserted the control
GFP-targeting miRNA (wt) into the 30 UTR of the
DsRed-Express gene under the control of a Tet-OFF
promoter construct. This plasmid was cotransfected with
the tetracycline transactivator protein expression plasmid
at a plasmid ratio that had been optimized to maximize
GFP silencing (Supplementary Figure S2), and GFP levels
were measured in the presence of varying concentrations
of the small-molecule inducer doxycycline (Figure 2G).
We found that the inducible promoter system exhibits
less silencing compared to the ligand-regulated miRNA
system in the absence of ligand (40 versus 25%
basal GFP expression levels). In addition, the dynam-
ic range of the inducible promoter system is similar to
that achieved with the ligand-regulated miRNA system
at high concentrations of ligand (2.1- versus 2.4-fold),
although the promoter system recovered to a higher
expression level. These results demonstrate that the regu-
latory performance of the integrated RNA-only control
system is comparable to that of an inducible promoter
system under these experimental conditions. Given the
practical advantages of an RNA-only system over
control strategies that require the expression of a
heterologous protein from a separate promoter, the
ligand-regulated miRNA system represents a significant
advance in conditional gene silencing technologies.
Framework modularity supports the integration of
different aptamer and miRNA targeting sequences
Ligand-responsive regulatory systems that display modu-
larity can be readily modified to change the targeted gene
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Figure 2. Ligand-responsive miRNAs enable ligand control of Drosha processing and gene silencing. (A) Design framework for ligand-responsive
miRNAs. The aptamer-binding core is integrated into the miRNA basal segments adjacent to the lower stem. Ligand binding increases the structured
nature of the aptamer. (B) Proposed relationship between Drosha processing (dashed gray line), target gene expression levels (black line), miRNA
basal segments structure and ligand addition in the case of a ligand-responsive miRNA. Unstructured basal segments lead to efficient processing and
gene silencing. Structured basal segments resulting from ligand binding inhibit Drosha processing. (C) Sequence and secondary structures of minimal
pri-miRNAs with a large bulge (m1) or the theophylline aptamer (th1) inserted into the basal segments. See Figure 1B for notation. (D) PAGE
Continued
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or recognized ligand without complete redesign. Such
systems are useful in facilitating the rapid implementation
of base designs in diverse applications. While most
ligand-responsive RNA regulator designs can be readily
modified to target different genes, only a fraction of the
developed designs have been shown to support direct in-
sertion of different aptamer sequences (12,28,29).
The targeted gene is specified by the mature miRNA
sequence in a miRNA regulatory element. Previous work
has shown that modifying the mature miRNA sequence in
natural miRNAs is sufficient to target different genes (30).
We found that altering the th1 miRNA to target a differ-
ent location in the GFP transcript (th2) preserved
silencing and the theophylline response in the cell-culture
assay, while scrambling the mature miRNA sequence
(th10) abolished silencing (Supplementary Figure S6).
Therefore, the mature miRNA sequence can be modified
in our ligand-responsive miRNA framework without
compromising the ligand-control function encoded
within the aptamer sequence.
To examine the modularity of the aptamer sequence, we
tested two additional aptamers that display different
lengths and secondary structures: the tetracycline
aptamer (31) and the xanthine aptamer (32). The binding
core of each aptamer was initially integrated adjacent to the
lower stem in place of the bulge (Figure 3A), and the
resulting miRNAs were tested using the cell-culture assay
in the presence or absence of the cognate ligand.
Hypoxanthine was used as a soluble alternative to
xanthine that binds the aptamer with comparable affinity
(32). Control miRNAs that produced similar GFP basal
levels to the ligand-responsive miRNAs were also tested
to determine any non-specific impact of ligand addition
on GFP levels. The miRNA harboring the tetracycline
aptamer (tc1) reduced GFP basal levels to 52% and
mediated a 1.5-fold increase in GFP levels in the presence
of tetracycline (Figure 3B). The control miRNA (m2) de-
livered a similar extent of silencing with negligible tetracyc-
line dependence, indicating that insertion of the
tetracycline aptamer rendered gene silencing sensitive to
tetracycline. However, compared to the theophylline
aptamer, insertion of the tetracycline aptamer imparted
reduced silencing and ligand sensitivity. The altered
silencing in the absence of ligand may be attributed to
the nature of the unbound aptamer structure, where the
tetracycline aptamer folds into a preformed pocket (33).
The altered regulatory response may be attributed to
aptamer affinity, the relative membrane permeability of
each small molecule and the extent to which each
aptamer adopts a more structured conformation upon
ligand binding.
Insertion of the binding core of the xanthine aptamer
(xa1) completely abolished silencing (Figure 3C). The size
of the bulge in the basal segments of xa1 was similar to
that in m4, the miRNA with the smallest bulge tested
(Figure 1B). Therefore, the small size of the xanthine-
binding core may similarly prevent proper Drosha pro-
cessing. We hypothesized that an aptamer with a small
binding core bulge can be made more unstructured by
including additional bulges, thereby restoring proper
processing. Most aptamers selected in vitro contain loops
that are separate from the binding core. To decrease the
structure of the basal segments without compromising
binding activity, we included the loop of the original
xanthine aptamer and inverted the aptamer sequence to
ensure hypoxanthine binding was proximal to the lower
stem (xa2). Results from the cell-culture assay show that
inserting the aptamer loop restored GFP silencing
(25% basal levels) and mediated a 2.1-fold increase in
GFP levels in the presence of hypoxanthine (Figure 3C),
whereas hypoxanthine had no effect on a control miRNA
with a similar silencing efficiency (m1). These studies
support the generality of our design strategy based on
the demonstrated ability of aptamer–ligand-binding inter-
actions to modulate miRNA processing and subsequent
targeted gene silencing.
Ligand-responsive miRNA clusters can be engineered to
achieve tunable genetic control
Multiple miRNAs have been found in natural clusters
within a single transcript (34), allowing cells to efficiently
regulate multiple miRNAs from a single promoter. By
integrating multiple miRNAs into the same transcript,
researchers have exploited this architecture to target
multiple genes or tune gene silencing (35–37). Integrating
ligand-responsive miRNAs into clusters would allow
tuning of the regulatory response, simultaneous regulation
of different targets and multi-input control of gene
expression.
Evidence from natural miRNA clusters suggests that
the spacer length between miRNAs can affect miRNA
levels (38). To examine the effects of spacer length on
gene silencing and ligand control in ligand-responsive
miRNA clusters, we inserted a second copy of the th1
miRNA upstream from the first copy in the 30 UTR of
the transcript encoding DsRed-Express. Different spacer
sequences were inserted between the two miRNA copies
that ranged from 2 to 112 nt and were selected from the
Figure 2. Continued
analysis of m1 and th1 subjected to the Drosha cleavage assay in the presence or absence of 5mM theophylline. See Figure 1C for notation.
(E) Relative GFP levels obtained from the cell-culture assay for constructs harboring th1 (blue) or a miRNA with basal segments similar to miR-30a
(wt, black) (Supplementary Figure S1). See Figure 1D and E for description of the assay. Transient transfections were conducted in the presence of
varying theophylline concentrations. (F) Relative GFP levels obtained from the cell-culture assay for constructs transiently transfected in the absence
(white) or presence of 1mM theophylline (gray) or 1mM caffeine (black). GFP levels were normalized to the construct lacking any miRNAs
(No miRNA) transfected under the same conditions. (G) Relative GFP levels obtained for the tet inducible promoter system. A plasmid encoding the
tetracycline transactivator was cotransfected with a plasmid encoding wt in the 30 UTR of DsRed-Express under doxycycline-inducible control in the
presence of varying doxycycline concentrations as part of the cell-culture assay. Error bars reflect the range of values from two (E and F) or three
(G) independent transfections conducted in the same cell-culture plate. See Supplementary Figure S4B–D for results from independent transfection
experiments for E–G, respectively.
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region downstream of the first miRNA copy (Figure 4A,
Supplementary Figure S1). We then performed the
cell-culture assay with each construct in the presence
or absence of theophylline. Adjacent placement of the
miRNAs compromised both silencing and the response
to theophylline, potentially due to miRNA misfolding or
steric hindrance of Drosha processing (Figure 4B).
Increasing the spacer length to 20 nt restored GFP
silencing, and extending the spacer length to 112 nt
further improved silencing (19 versus 34% basal levels)
and the theophylline response (3.0- versus 2.1-fold
increase) as compared to the single-copy construct.
These results suggest that separating identical miRNAs
by at least 20 nt improves processing and gene silencing.
Gene silencing and the dynamic range improved when
two copies of a ligand-responsive miRNA were separated
by the longest spacer tested (112 nt). As miRNAs in
natural clusters are assumed to be individually processed,
we expected that inserting additional copies separated by
appropriate spacer lengths would further improve
silencing and the theophylline response. Constructs har-
boring up to four copies of the theophylline-responsive,
GFP-targeting miRNA (th1) or four copies of the
non-targeting variant (th10) separated by the longest
spacer sequence were subjected to the cell-culture assay.
Each additional copy of th1 improved GFP silencing
(36% basal levels for one copy versus 6% basal levels
for four copies) and the theophylline response (2.0-fold
increase for one copy versus 4.7-fold increase for four
copies), whereas four copies of th10 had no effect on
GFP levels (Figure 4C). The addition of each miRNA
copy increased silencing and the dynamic range
(measured as the ratio of GFP levels in the presence or
absence of theophylline) by providing more miRNAs for
Drosha recognition and more opportunities to inhibit
processing. Despite the improved dynamic range, the
addition of each miRNA copy decreased GFP levels in
the presence of theophylline. This decrease may be
attributed to the inability to access higher theophylline
concentrations due to cytotoxicity (39) or incomplete
inhibition of Drosha processing when theophylline is
bound to the aptamer. Overall, changing the copy
number of ligand-responsive miRNAs provides one
approach to coordinately tune gene silencing and the
dynamic range.
Ligand-responsive miRNA clusters can regulate
endogenous genes
Most of the synthetic ligand-responsive RNA-based
regulatory systems are encoded in the target transcript,
providing regulation in cis (7,8). However, the regulation
of endogenous genes through cis-regulatory strategies is
currently limited by the lack of directed recombination
technologies. To test whether ligand-responsive miRNAs
provide a trans-regulatory strategy for the effective regu-
lation of endogenous genes, we incorporated a mature
miRNA sequence against the endogenous La gene into
the control miRNA wt (La1) and the theophylline
aptamer-containing miRNA th1 (La2) (Supplementary
Figure S7). Four copies of each miRNA separated by
A
B
C
Figure 3. Ligand-responsive miRNAs can accommodate different
aptamers to tailor the input-responsiveness of the regulatory system.
(A) Sequence and secondary structure of GFP-targeting miRNAs with
the tetracycline (tc1) or hypoxanthine (xa1, xa2) aptamers inserted into
the basal segments. tc1 and xa1 contain the aptamer-binding core, xa2
contains the aptamer-binding core and an adjacent internal loop
present in the original aptamer. See Figure 1B for notation. (B and
C) Relative GFP levels obtained from the cell-culture assay for
constructs transiently transfected in the absence (white) or presence
of either 100mM tetracycline (gray) or 5mM hypoxanthine (black).
See Figure 1D and E for description of the assay. m1 and m2 were
used as negative controls as they result in similar levels of GFP
silencing as xa2 and tc1, respectively, in the absence of ligand. Error
bars reflect the range of values from two independent transfections
conducted in the same cell-culture plate. See Supplementary
Figure S4E and F for results from independent transfection experi-
ments for (B) and (C), respectively.
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the longest spacer sequence were inserted into the
30-UTR of the transcript encoding DsRed-Express, and
the resulting constructs were stably integrated into a
single site in 293-Flp-In cells. Stable cell lines were
grown in the presence or absence of 1.5mM theophylline
for over 1 week and assayed for relative La transcript
levels by qRT–PCR. The reduced theophylline concen-
tration from 5 to 1.5mM was used for all stable expres-
sion studies to maintain 293 growth for extended periods
of time (data not shown). Four copies of either La1 or
La2 resulted in relatively strong silencing of the La target
(19 and 22% basal levels, respectively), and only La2
mediated a theophylline-dependent increase of 2.2-fold
in La transcript levels (Supplementary Figure S7). The
observed fold-change represents a fraction of the full
dynamic range since higher theophylline concentrations
could not be used. These results demonstrate that
ligand-responsive miRNAs can control endogenous
genetic targets, providing a control strategy that does
not physically disrupt the locus of the target gene.
Ligand-responsive miRNAs can control gene
expression in cis
Drosha cleavage is anticipated to separate the coding
region from the poly(A) tail when the miRNA is located
in the 30 UTR, resulting in the prevention of translation
and facilitation of mRNA degradation (Figure 5A).
Drosha was recently shown to cleave a naturally occurring
pseudo-miRNA in the transcript of DGCR8 to regulate
the activity of the Microprocessor (40). In addition,
introducing a 30 UTR-encoded miRNA was shown to
downregulate expression from the transcript harboring
the miRNA (41). From these insights we hypothesized
that ligand-responsive miRNAs could be utilized to
regulate gene expression in cis.
We first examined the effects of ligand-responsive
GFP-targeting miRNAs encoded in the 30 UTR of the
DsRed-Express gene on DsRed expression. DsRed-
Express levels were quantified by flow cytometry under
similar conditions as in the trans-targeted gene silencing
experiments. The presence of one copy of th1 reduced
DsRed levels to 51% and introducing additional copies
with a spacer length of 112 nt further reduced DsRed
levels (21% for four copies). Furthermore, two copies
were sufficient to introduce ligand regulation, with a
maximum observed fold-induction of 2.2 for three
miRNA copies (Figure 5B). Similar effects were
observed with four copies of the non-targeting miRNA
(th10), indicating that DsRed transcript silencing and
ligand control are independent of mature miRNA
activity and GFP targeting. qRT–PCR analysis confirmed
that mRNA destabilization is the predominant regulatory
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Figure 4. Synthetic ligand-responsive miRNA clusters allow tuning of
the regulatory response. (A) Schematic of a synthetic miRNA cluster in
which multiple ligand-responsive miRNAs are placed into the 30 UTR
of a transgene-encoded transcript. The spacer sequence downstream of
each miRNA (indicated in red) was kept consistent, and the spacer
length (L) was varied between 2 and 112 nt. Multiple copies (from 1
to 4) of a single miRNA were sequentially inserted. (B) The impact of
spacer length between two theophylline-responsive GFP-targeting
miRNAs (2, th1) on gene silencing in the presence (gray) or
absence (white) of 5mM theophylline. The GFP-targeting miRNAs
were cloned into the plasmid constructs and characterized through
the cell-culture assays described in Figure 1D. GFP levels are
reported as described in Figure 2F. The GFP silencing from a
single-copy theophylline-responsive miRNA construct (1, th1) is
shown for comparison. (C) The impact of ligand-responsive miRNA
copy number on gene silencing and dynamic range. Multiple copies
(#) of the GFP-targeting (th1) or non-targeting (th10, Figure S6)
theophylline-responsive miRNAs were cloned into the plasmid
constructs described in Figure 1D using the largest spacer length
tested (112 nt). GFP levels were characterized and reported as described
in Figure 1D, and the dynamic range is reported as the ratio of GFP
levels in the presence and absence of theophylline. Error bars reflect the
range of values from two independent transfections conducted in the
same cell-culture plate.
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mechanism of ligand-responsive miRNAs acting in cis
(Supplementary Figure S8). A similar analysis of the
La-targeting miRNAs revealed that four copies of either
La1 or La2 reduced DsRed-Express levels 25-fold in the
absence of theophylline, again supporting the notion that
this cis-effect is not affected by RNAi-related downstream
events (Supplementary Figure S7C). In addition, the
miRNA containing the theophylline aptamer (La2)
conferred a 3-fold increase in DsRed levels in the
presence of theophylline that was not observed for the
construct lacking the theophylline aptamer (La1)
(Supplementary Figure S7C). These results suggest that
ligand-responsive miRNAs can regulate transcripts in cis
by modulating Drosha cleavage.
Self-targeting miRNAs combine trans- and cis-regulation
for a tighter control system
Ligand-responsive miRNAs can regulate genes in trans
through RISC targeting and in cis through Drosha
cleavage. A control system based on combining both
modes of regulation into ‘self-targeting miRNAs’ may
offer tighter regulation while still operating within the
30 UTR of the transgene-encoding transcript. We de-
veloped a dual-acting miRNA circuit based on the inser-
tion of ligand-responsive miRNAs or miRNA clusters
into the 30 UTR of a GFP transcript targeted by these
miRNAs (Figure 6A). Here, the presence of ligand is
expected to modulate direct destabilization of the
cleaved transcript and subsequent RISC-mediated inacti-
vation of other target transcripts. We tested five constructs
to assess the relative impact of copy number and the cis
and trans-regulatory mechanisms (Figure 6B). The result-
ing constructs were stably integrated into 293-Flp-In cells
to ensure consistent expression. Cells were grown in the
presence or absence of 1.5mM theophylline for over a
week and analyzed by flow cytometry (Figure 6B and
Supplementary Figure S9).
Flow cytometry results revealed that each parameter
(copy number, cis-regulation, cis and trans regulation)
contributed to gene silencing and the theophylline
response. The non-targeting miRNAs (th10) had the
weakest impact, with 59% GFP basal levels and a
1.5-fold induction from theophylline with single copy.
The self-targeting miRNAs (th1) had a much stronger
impact, with 27% basal levels and a 2.3-fold induction
from theophylline at single copy. Increasing the copy
number of the non-targeting and self-targeting miRNAs
from one to four improved both GFP silencing and the
theophylline response, with 4% basal levels and a 4.1-fold
induction from theophylline for four copies of the
self-targeting miRNA. These results demonstrate the
diverse tuning capabilities when encoding ligand-
responsive miRNAs in a transcript 30-UTR by implement-
ing self-targeting and non-targeting miRNAs at different
copy numbers.
We performed time course studies on the dual-acting
miRNA circuits to examine the dynamic properties of
these regulatory systems. Cell lines were grown in the
presence of theophylline for 6 days and then grown in
media without theophylline for another 6 days. Cell lines
harboring th1 or th10 in single or four copies exhibited
increasing GFP levels when grown in the presence of
theophylline and reached steady-state levels by Day 6
(Figure 6C and Supplementary Figure S10). GFP levels
decreased upon removal of theophylline and returned to
original levels after 4–6 days of growth in the absence of
theophylline, indicating that the genetic control exerted by
ligand-responsive miRNAs is reversible. After theophyl-
line addition, cells containing the self-targeting miRNAs
required an extra day to reach steady-state in comparison
to cells containing the non-targeting miRNAs, likely
due to the slow turnover of activated RISC molecules
(Supplementary Figure S10) (42). The particular response
dynamics associated with the cis and cis/trans-regulatory
mechanisms offer yet another design parameter when
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Figure 5. Ligand-responsive miRNAs can control transgene expression
in cis. (A) Schematic of gene regulation in cis through miRNA
cleavage. Drosha processing of the miRNA located in the 30 UTR of
a transcript encoding DsRed Express separates the coding region from
the poly(A) tail, thereby inactivating the transcript. (B) The impact of
ligand-responsive miRNA copy number on expression of the transgene
through regulation in cis in the presence (gray) or absence (white) of
5mM theophylline. DsRed-Express levels of the constructs tested in
Figure 4C were characterized through identical cell-culture assays.
The population mean of DsRed-Express fluorescence from transiently
transfected HEK 293 cells stably expressing GFP was normalized to
that from a construct lacking any miRNAs (no miRNA) transfected
under the same conditions. Error bars reflect the range of
values from two independent transfections conducted in the same
cell-culture plate.
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specifying the regulatory performance of ligand-responsive
miRNAs.
DISCUSSION
The construction of synthetic ligand-responsive miRNAs
provides new insights into miRNA structure–function
relationships
In this work we explored the structural requirements for
Drosha processing and utilized this mechanistic insight to
develop a regulatory framework based on the control of
Drosha cleavage. While previous work had demonstrated
that both strands of the basal segments must be present
and unpaired for efficient Drosha processing (3,21,23), our
work evaluated the effects of bulge size in the basal
segments on Drosha processing and subsequent gene
silencing. In particular, we show that Drosha processing
and gene silencing can be modulated by making small
changes to the bulge size, revealing a graded structure–
function relationship.
Our work also demonstrates that the structural changes
that occur upon aptamer–small molecule ligand binding
are sufficient to drive the miRNA structure into a
less-processable conformation. This finding provides an
important contribution to the field by demonstrating
how unique properties of RNA structure and molecular
binding can impart complex functional properties onto an
important class of regulatory molecules. The use of three
aptamer–ligand pairs supports the ability of our
integrated platform to control miRNA activity with
diverse molecules, such as metabolites and disease
markers, against which aptamers can be selected. In
addition to selected aptamers, aptamers present in
natural riboswitches may also provide sequences that
can be integrated into such synthetic regulatory platforms
(43). While most aptamers contain a bulge and stem-loop,
alternative structures (44–46) may be incompatible with
the described ligand-responsive miRNA framework. To
address such broader implementation challenges, future
work may focus on the development of modified frame-
works that accept more diverse aptamer structures, the
modification of aptamer selection procedures to preferen-
tially select bulge-loop structures or the development of
in vivo screening strategies for RNA-based regulatory
systems that identify sequences that function as integrated
sensing components (47).
Our results also indicate that the variable spacing and
secondary structure within intervening sequences of
natural-occurring miRNA clusters may be a key factor
0 mM theo
0
2
4
6
8
10
12
0 2 4 6 8 10 12
days
G
FP
(%
)
1.5 mM theo
1X 4X 4X
th1 th1’
1X 1X
wt
0
20
40
60
80
100
120
G
FP
(%
)
copy #
1.3 0.9 2.3 4.1 1.5 1.8 ratio
No
miRNA
BA
C
AAAAAAAgfp
RNAi
Drosha
Figure 6. Self-targeting miRNAs provide an enhanced regulatory response. (A) Schematic of the miRNA regulatory circuit associated with
self-targeting miRNAs. Self-targeting miRNAs are located in the 30 UTR of the targeted transcript encoding GFP such that Drosha cleavage
and RISC targeting downregulate expression. Both events are inhibited by ligand binding to the aptamer contained in the miRNA basal segments.
(B) Relative GFP levels for cells stably expressing the self-targeting miRNA constructs grown in the presence (gray) or absence (white) of 1.5mM
theophylline for over a week. Gene silencing from one (1) or four (4) copies of a theophylline-responsive self-targeting miRNA (th1) and one or
four copies of a theophylline-responsive non-targeting miRNA (th10) were determined, where multiple copies were separated by the largest spacer
length (112 nt). One copy of a self-targeting miRNA with basal segments similar to miR-30a (wt) was used as a negative control. The dynamic range
is reported as the ratio of GFP levels in the presence and absence of theophylline. (C) Temporal response of the relative GFP levels to a change in
ligand concentration for cell lines stably expressing ligand-responsive miRNAs. Representative time course data is shown for cells expressing the
miRNA construct containing four copies of th1. Cells were grown in the presence of 1.5mM theophylline for 6 days and then transferred to media
without theophylline for 6 days. Error bars reflect the range of values from cells grown in three separate wells in the same cell-culture plate. See
Supplementary Figure S4G for results from an independent experiment for (B).
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in miRNA processability and an evolutionary factor to
tune miRNA processing and subsequent gene silencing
activity. Future studies that correlate the secondary struc-
tures of natural miRNA clusters with the extent of pro-
cessing of each miRNA will provide further insight into
this relationship. From this enhanced understanding, mo-
lecular engineers may be able to design synthetic cluster
expression platforms that minimize cluster length, while
maximizing or even tuning the processing of the encoded
miRNAs (37). Scalable synthetic cluster expression
platforms will be important tools in the development of
gene regulatory circuits based on simultaneous implemen-
tation of multiple ligand-responsive miRNAs to achieve
finely tuned, combinatorial gene expression control
schemes.
Finally, the synthetic ligand-responsive miRNA systems
reported here may foreshadow the discovery of a preva-
lent strategy used by natural systems to achieve
sophisticated control over miRNA regulatory networks.
Since natural riboswitches functioning as miRNA regula-
tors have not yet been discovered, the design of synthetic
systems reported here suggests relevant architectures to
assist in the identification of natural counterparts. For
instance, bioinformatics searches for conserved sequences
and secondary structures in the miRNA basal segments
may uncover molecular recognition elements that
modulate Drosha processing. Researchers have previously
identified mechanisms that modulate miRNA activity
based on binding interactions between RNA-binding
proteins and miRNA loops (48) and target sites (49),
lending further support to the likelihood of an as yet un-
discovered natural regulatory strategy based on
small-molecule control of miRNA activity.
Ligand-responsive miRNAs provide unique capabilities as
research tools and therapeutic molecules
Given the considerable interest in using miRNAs as
research tools and for therapeutic interventions (50,51),
the ability to implement user-defined molecular control
over miRNA regulatory effects is critical to facilitating
applications in basic research and applied medicine.
Previous strategies have expressed miRNAs from indu-
cible promoter systems to achieve control over
miRNA-mediated gene silencing (52). However, a pro-
grammable, integrated RNA-only platform provides
several unique advantages that will support new studies
and applications of miRNA regulatory systems. For
example, strategies based on inducible promoter systems
require the expression of additional transgenic proteins
encoding transcriptional regulators. The stable,
long-term expression of multiple heterologous proteins
represents a significant challenge in primary cells and or-
ganisms. In addition, the clinical application of such
systems is limited by concerns associated with potential
nonspecific immunogenicity of the heterologous protein
components. In contrast, the ligand-controlled miRNA
platform integrates the desired regulatory function into a
compact RNA-only system that does not require separate
expression constructs for the control system, providing a
significant implementation advantage.
The dynamic range of the ligand-responsive miRNA
system (2- to 5-fold) was limited in part by the inability
to fully inhibit Drosha processing. While it is possible that
ligand binding to the miRNA basal segments does not
fully inhibit processing, another likely contribution is the
upper limit on the applied ligand concentration for the
systems reported here. Incorporating higher-affinity
aptamers or using ligands with desirable pharmacokinetic
properties such as high cell permeability and low cytotox-
icity may improve the dynamic range of the miRNA
switches and fully inhibit processing. However, even
with a limited dynamic range, other studies have shown
such gene regulatory activities to be sufficient to control a
number of physiological processes (29,53,54). The ability
to finely tune the regulatory performance of our platform
will aid in optimizing the system response in the presence
and absence of selected ligands.
We demonstrated that the ligand-responsive miRNA
platform is modular such that different aptamers can be
directly integrated into the basal segment region to change
the effector controlling gene silencing. Because new
aptamers can be generated through standard selection
schemes (55), the integrated RNA control system
supports the direct construction of systems that regulate
miRNA silencing through many different user-defined ef-
fectors (a property that is not shared with commonly used
protein-based regulatory systems). For example, by
integrating aptamers that bind pharmaceutical drugs,
systems can be built that control miRNA silencing
activities with clinically relevant drug molecules to
enable safer and more effective therapeutic strategies for
cell-based and gene therapies. In addition, the described
platform can be used to build systems that control
miRNA activities in response to endogenous metabolites,
proteins and hormones to enable targeting of gene
silencing to cell-specific states, including stem cells,
tissue-specific cells, cancer cells, cells suffering from
metabolic diseases and cells infected with pathogens. By
implementing ligand-responsive miRNAs that respond
to endogenous molecules, these regulators will provide
a platform for reprogramming the cellular state according
to the intracellular environment, supporting autono-
mous approaches to tissue engineering and disease
treatment.
Finally, the ligand-responsive miRNA system provides
a scalable platform for implementing multi-input, multi-
output control schemes in mammalian cells. Specifically,
the described system can be extended to the design of
miRNA clusters composed of different miRNA silencing
activities controlled by independent input signals in a
compact platform. Such systems will allow for
the simultaneous and independent perturbation of differ-
ent components within a biological network, supporting
the complex probing and programming of cellular
function.
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